913375-90-3 Usage
Molecular Structure
1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxylic acid has a complex molecular structure that includes a pyrazole ring, a phenyl group, a pyridine group, and a carboxylic acid functional group.
Pyrazole Ring
The compound contains a pyrazole ring, which is a five-membered heterocyclic ring with two nitrogen atoms and one oxygen atom.
Phenyl Group
A phenyl group is present in the compound, which is a benzene ring with a hydrogen atom replaced by a side chain.
Pyridine Group
The compound also features a pyridine group, which is a six-membered heterocyclic ring with one nitrogen atom.
Carboxylic Acid Functional Group
The molecule has a carboxylic acid functional group, which consists of a carbonyl group (C=O) and a hydroxyl group (OH) bonded to the same carbon atom.
Pharmaceutical Applications
Due to its complex molecular structure, 1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxylic acid has potential pharmaceutical applications, as it may interact with biological systems.
Further Research and Testing
The precise properties and potential uses of this compound would depend on additional research and testing to determine its specific interactions and effects on biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 913375-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,3,7 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 913375-90:
(8*9)+(7*1)+(6*3)+(5*3)+(4*7)+(3*5)+(2*9)+(1*0)=173
173 % 10 = 3
So 913375-90-3 is a valid CAS Registry Number.
913375-90-3Relevant articles and documents
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series
Liu, Longbin,Norman, Mark H.,Lee, Matthew,Xi, Ning,Siegmund, Aaron,Boezio, Alessandro A.,Booker, Shon,Choquette, Debbie,D'Angelo, Noel D.,Germain, Julie,Yang, Kevin,Yang, Yajing,Zhang, Yihong,Bellon, Steven F.,Whittington, Douglas A.,Harmange, Jean-Christophe,Dominguez, Celia,Kim, Tae-Seong,Dussault, Isabelle
, p. 1868 - 1897 (2012/05/04)
As part of our effort toward developing an effective therapeutic agent for c-Met-dependent tumors, a pyrazolone-based class II c-Met inhibitor, N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazole-4-c
